No Patient Left Behind
No Patient Left Behind is a Washington, D.C.-based nonprofit advocacy coalition of biotech innovators, investors, healthcare professionals, and patients that lobbies policymakers on drug pricing, insurance reform, FDA modernization, and biomedical innovation incentives.
- Company typePrivate
- Founded2023
- HeadquartersWashington, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What No Patient Left Behind does
No Patient Left Behind (NPLB) is a Washington, D.C.-based nonprofit advocacy organization that operates as a coalition of biotechnology innovators, investors, economists, healthcare professionals, and patients. Founded in 2023 and fiscally sponsored by A Mission Edge, NPLB's stated purpose is to support policy solutions that improve patient affordability while preserving the innovation ecosystem, with policy priorities spanning the Inflation Reduction Act, FDA and NIH modernization, Most Favored Nation drug pricing, and insurance reform. Its deliverables are non-commercial: advocacy letters to Congress and federal agencies, public comments to the FDA/CMS/HHS/USTR, research and policy publications, an annual Impact Report, the NPLB Fellowship program, the First Responder action-alert network, the Community Quests and Patient Stories engagement platforms, the Fine Print webinar series, and an educational comics library.
NPLB has no commercial products, software, or proprietary technology platform; its underlying "technology" is a Squarespace website plus standard advocacy infrastructure (donor support, EveryAction petitioning, LinkedIn, YouTube). Revenue is generated exclusively through donations processed via nopatientleftbehind.donorsupport.co, with no disclosed funding rounds, grants, foundation backers, or audited financials. The organization is led by founder Peter Kolchinsky, with a Steering Committee and Advisory Councils, and transitioned to staffed executive leadership with the February 9, 2026 appointment of Priscilla VanderVeer as Executive Director. Headcount sits in the 1–10 band and growth has been expressed in coalition scale (1,000+ signatories on a 2022 IRA letter, 100+ biotech executives on a separate FDA leadership recommendation, 33 investors managing $86B backing detailed IRA critiques) rather than in headcount or disclosed revenue.
No Patient Left Behind firmographics
Firmographics- Name
- No Patient Left Behind
- Legal name
- No Patient Left Behind
- Website
- https://nopatientleftbehind.org
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- No Patient Left Behind is a Washington, D.C.-based nonprofit advocacy coalition of biotech innovators, investors, healthcare professionals, and patients that lobbies policymakers on drug pricing, insurance reform, FDA modernization, and biomedical innovation incentives.
- Ownership category
- akta.pro rank
No Patient Left Behind industry classification
Industry- Product category
- Healthcare Policy Advocacy
- akta.pro primary industry
- Patient Advocacy, Navigation & Access to Care (BPAGACAH)
- akta.pro secondary industry
- Patient Access Programs & Affordability (Copay/Hubs/PSP) (HLAIAKAG)
Keywords
Where No Patient Left Behind is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Markets served
No Patient Left Behind business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Donations and Support: NPLB is a nonprofit organization that relies on donations from supporters. The website includes a donation page (nopatientleftbehind.donorsupport.co) suggesting individual and potentially corporate contributions fund operations.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels10 records
No Patient Left Behind product offering
Product offeringCore offering
No Patient Left Behind is a nonprofit policy advocacy network that mobilizes biotechnology innovators, investors, economists, healthcare professionals, and patients to influence U.S. healthcare and biotech policy. Its work centers on advocating for patient access to affordable medicines, opposing price controls that harm innovation, supporting FDA/NIH modernization, and pushing insurance reform to reduce out-of-pocket costs. Deliverables include advocacy letters, public comments to regulatory bodies, research reports, educational comics, webinars, and a fellowship program.
Product overview
No Patient Left Behind is a policy advocacy organization, not a product company. It does not offer commercial software products or technology services. The organization's offerings consist of educational and advocacy resources including policy letters, research publications, educational comics, video content, webinars, and community engagement initiatives focused on healthcare affordability, biotech innovation policy, and patient access to medicines. Key programmatic offerings include its Resource Library containing advocacy letters, research reports, presentations, and educational animations; Community Quests video series featuring biotech innovators; the NPLB Fellowship program; policy positions on topics including the Inflation Reduction Act, FDA modernization, Most Favored Nation pricing, and insurance reform; and the annual Impact Report documenting policy advocacy outcomes.
Differentiator
Problem solved
Functional benefit
Products and services
- NPLB Fellowship Program
Quantifiable outcome
- Influenced FDA leadership recommendations with 100+ biotech executive signatories
- +1 more outcomes
Companies that use No Patient Left Behind
Customer profileSegments3 records
Ideal customer profiles2 records
No Patient Left Behind technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
No Patient Left Behind partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- A Mission Edge ProjectcoreNPLB is operated as a project under A Mission Edge, a nonprofit infrastructure organization that provides operational support for charitable initiatives.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
No Patient Left Behind competitors and assessment
Company assessmentDirect peers
- Patients For Affordable Drugs: Independent patient advocacy nonprofit focused specifically on lowering prescription drug prices through policy reform. Most directly comparable to NPLB in mission (drug affordability) and tactics (grassroots mobilization, public comments, congressional engagement).
- Patients Rising: Patient advocacy organization advocating for access to therapies and against insurance barriers while supporting medical innovation. Shares NPLB's bridge narrative between innovation and access and similar patient-stories storytelling approach.
- National Patient Advocate Foundation: Patient advocacy nonprofit working on healthcare affordability, insurance reform, and access to treatments through federal and state policy engagement. Comparable in policy advocacy model and patient-centered framing.
- Aimed Alliance: Nonprofit advocating for patient access to appropriate medical care, including insurance coverage and drug pricing reform. Operates with a similar lean team model focused on regulatory and legislative engagement.
Broad incumbents
- Biotechnology Innovation Organization (BIO): Large industry trade association representing biotech companies, with major lobbying and policy operations on FDA, IP, and drug pricing. Broader and far better-resourced than NPLB, but converges on innovation-protection advocacy.
- Pharmaceutical Research and Manufacturers of America (PhRMA): Primary pharma industry trade association, dominant lobbying force on drug pricing, IP, and FDA policy. Represents the establishment position NPLB aligns with on innovation, but with vastly larger operational resources.
- American Cancer Society Cancer Action Network (ACS CAN): Advocacy affiliate of the American Cancer Society, focused on cancer-related policy including drug access and insurance coverage. Comparable policy-advocacy infrastructure, but disease-specific rather than cross-cutting like NPLB.
Emerging players
- Families USA: National nonprofit advocating for affordable, high-quality healthcare, including drug pricing and insurance reform. Operates in adjacent space with a consumer/affordability tilt that contrasts with NPLB's industry-friendly framing.
Others
- AARP Public Policy Institute: Policy and advocacy arm of AARP focused on healthcare affordability, drug pricing, and Medicare. An adjacent rather than direct peer, but a major counterpart voice in drug-pricing debates that NPLB engages against.
- Public Citizen Health Research Group: Consumer advocacy group advocating for stronger drug pricing regulation and against pharma industry abuses. Thematically adjacent to NPLB but ideologically opposed on innovation-vs-access balance.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
No Patient Left Behind social profiles
Digital presenceNo Patient Left Behind financial estimates
Financial estimateRevenue estimate
Valuation estimate
No Patient Left Behind leadership team
Management profileNumber of profiles
Profiles2 records
No Patient Left Behind funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
No Patient Left Behind M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about No Patient Left Behind
What does No Patient Left Behind do?
No Patient Left Behind is a nonprofit policy advocacy network that mobilizes biotechnology innovators, investors, economists, healthcare professionals, and patients to influence U.S. healthcare and biotech policy. Its work centers on advocating for patient access to affordable medicines, opposing price controls that harm innovation, supporting FDA/NIH modernization, and pushing insurance reform to reduce out-of-pocket costs. Deliverables include advocacy letters, public comments to regulatory bodies, research reports, educational comics, webinars, and a fellowship program.
When was No Patient Left Behind founded?
No Patient Left Behind was founded in 2023. It employs 1 to 10 people.
Where is No Patient Left Behind based?
No Patient Left Behind is headquartered in Washington, United States, in the North America region.
How does No Patient Left Behind make money?
One revenue line is on record: donations and Support.
Who are No Patient Left Behind's main competitors?
Direct peers on record are Patients For Affordable Drugs, Patients Rising, National Patient Advocate Foundation and Aimed Alliance. Broad incumbents are Biotechnology Innovation Organization (BIO), Pharmaceutical Research and Manufacturers of America (PhRMA) and American Cancer Society Cancer Action Network (ACS CAN). Families USA is listed as an emerging player. Others are AARP Public Policy Institute and Public Citizen Health Research Group.
Does No Patient Left Behind have an API?
No public API is recorded for No Patient Left Behind.
What industry is No Patient Left Behind in?
No Patient Left Behind's product category is Healthcare Policy Advocacy. Its primary akta.pro industry code is BPAGACAH, Patient Advocacy, Navigation & Access to Care, with a secondary code of HLAIAKAG, Patient Access Programs & Affordability (Copay/Hubs/PSP).